SignatureFD’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1K | Sell |
962
-399
| -29% | -$7.1K | ﹤0.01% | 2111 |
|
|
2025
Q1 | $24.3K | Buy |
1,361
+130
| +11% | +$2.32K | ﹤0.01% | 1951 |
|
|
2024
Q4 | $36.7K | Sell |
1,231
-48
| -4% | -$1.43K | ﹤0.01% | 1729 |
|
|
2024
Q3 | $20K | Sell |
1,279
-365
| -22% | -$5.71K | ﹤0.01% | 2034 |
|
|
2024
Q2 | $28.2K | Buy |
1,644
+627
| +62% | +$10.7K | ﹤0.01% | 1798 |
|
|
2024
Q1 | $15.9K | Buy |
1,017
+201
| +25% | +$3.14K | ﹤0.01% | 2104 |
|
|
2023
Q4 | $12.2K | Buy |
816
+106
| +15% | +$1.58K | ﹤0.01% | 2159 |
|
|
2023
Q3 | $11.5K | Buy |
710
+182
| +34% | +$2.94K | ﹤0.01% | 2128 |
|
|
2023
Q2 | $21.9K | Sell |
528
-352
| -40% | -$14.6K | ﹤0.01% | 1835 |
|
|
2023
Q1 | $52.9K | Sell |
880
-92
| -9% | -$5.53K | ﹤0.01% | 1365 |
|
|
2022
Q4 | $71.3K | Sell |
972
-76
| -7% | -$5.58K | ﹤0.01% | 1174 |
|
|
2022
Q3 | $80K | Sell |
1,048
-507
| -33% | -$38.7K | ﹤0.01% | 1064 |
|
|
2022
Q2 | $108K | Buy |
1,555
+180
| +13% | +$12.5K | ﹤0.01% | 951 |
|
|
2022
Q1 | $114K | Buy |
1,375
+852
| +163% | +$70.6K | ﹤0.01% | 975 |
|
|
2021
Q4 | $39K | Buy |
523
+197
| +60% | +$14.7K | ﹤0.01% | 1447 |
|
|
2021
Q3 | $38K | Sell |
326
-119
| -27% | -$13.9K | ﹤0.01% | 1450 |
|
|
2021
Q2 | $99K | Buy |
445
+60
| +16% | +$13.3K | ﹤0.01% | 960 |
|
|
2021
Q1 | $51K | Buy |
385
+45
| +13% | +$5.96K | ﹤0.01% | 1163 |
|
|
2020
Q4 | $59K | Buy |
340
+49
| +17% | +$8.5K | ﹤0.01% | 1001 |
|
|
2020
Q3 | $32K | Buy |
291
+175
| +151% | +$19.2K | ﹤0.01% | 1172 |
|
|
2020
Q2 | $7K | Hold |
116
| – | – | ﹤0.01% | 1688 |
|
|
2020
Q1 | $8K | Buy |
116
+101
| +673% | +$6.97K | ﹤0.01% | 1550 |
|
|
2019
Q4 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 2058 |
|